Chloe Kim Is Changing the Conversation Around ADHD in Women with Qelbree® for ‘Ms. Represented’ Campaign
Key Highlights
- ➤Qelbree reaches approximately 3 million prescriptions filled since its 2021 launch
- ➤Qelbree is the #1 prescribed branded non-stimulant ADHD medication as of May 2026
- ➤Supernus expands Qelbree’s ‘Ms. Represented’ campaign with professional snowboarder Chloe Kim
- ➤Chloe Kim diagnosed with ADHD as an adult, becoming a paid Supernus spokesperson
Expert Statements
Chloe Kim, Professional snowboarder and paid spokesperson for Supernus Pharmaceuticals
“When I was diagnosed with ADHD, so much about what I had been experiencing finally made sense”
Chloe Kim, Professional snowboarder and paid spokesperson for Supernus Pharmaceuticals
“I hope that by sharing my story, more women feel empowered to ask questions, seek support, and know that having ADHD doesn’t limit what they’re capable of achieving.”
Jack A. Khattar, President and Chief Executive Officer of Supernus Pharmaceuticals
“Through the ‘Ms. Represented’ campaign, we're continuing to challenge the misconceptions that have left women's experiences with ADHD overlooked for too long”
Jack A. Khattar, President and Chief Executive Officer of Supernus Pharmaceuticals
“Chloe brings an important perspective to that mission, and as we mark five years of Qelbree, we remain committed to raising awareness and providing a non-stimulant treatment option to help people manage their ADHD symptoms.”
* The ‘Ms. Represented’ campaign expands its reach with professional snowboarder Chloe Kim, who shares her ADHD experience to help connect with a younger generation of women. * More than 60% of U.S. women who reported ever receiving an ADHD diagnosis were first diagnosed in adulthood, underscoring the importance of recognizing experiences that don't fit familiar perceptions of the condition.(1) * Chloe is partnering with Qelbree, the #1 prescribed branded non-stimulant ADHD medication as of May 2026 which has reached approximately 3 million prescriptions filled since launch in 2021.* ROCKVILLE, Md., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Professional snowboarder Chloe Kim is bringing her personal attention-deficit/hyperactivity disorder (ADHD) journey to ‘Ms. Represented,’ a campaign from Supernus Pharmaceuticals for Qelbree (viloxazine extended-release capsules), a once-a-day, non-stimulant ADHD treatment for people ages 6 years and older. Diagnosed with ADHD as an adult, Chloe didn’t recognize her own experience in familiar portrayals of ADHD. Now, as a paid spokesperson for Supernus, she is opening up about her journey to change the conversation and help other women feel seen, understood, and represented.
Get started
Create a free account to read the full story.